Early Completion of Model-Assisted Designs for Dose-Finding Trials Accurate assessment of a molecular classifier that guides patient care is of paramount importance in precision oncology. Recent years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback